- Very limited direct evidence: No well-designed human clinical trials have specifically tested vitamin K2 for improving sleep quality.
- Indirect links exist but are speculative: K2's roles in calcium regulation and nervous-system function have prompted theoretical interest, but these mechanisms have not been translated into sleep-specific research.
- Don't skip K2 for other reasons: If you're deficient or have bone/cardiovascular health concerns, K2 may still be worth discussing with a doctor — just not for sleep.
- Better-evidenced sleep supplements exist: Magnesium, melatonin, and glycine have more direct sleep research behind them if that's your primary goal.
What the evidence shows
Let's be direct: as of the most recent literature review, there are no published randomised controlled trials (RCTs) specifically examining vitamin K2 and sleep quality in humans. A search of the primary databases turns up no dedicated trials, no dose-finding studies, and no polysomnography data linking K2 supplementation to measurable improvements in sleep latency, sleep duration, or sleep architecture.
What does exist is a thin layer of circumstantial interest. One area that occasionally gets cited is the relationship between vitamin K-dependent proteins and neurological function. Menaquinone (the K2 family) has been detected in brain tissue, and some K-dependent proteins — such as Gas6 and Protein S — are expressed in the nervous system and have roles in neuronal survival and myelination (Ferland, 2012). Whether any of this translates to subjective or objective sleep benefit in healthy or sleep-disordered adults is entirely unknown.
There is also population-level data associating overall dietary vitamin K intake with some health outcomes, but these observational studies do not isolate K2, do not measure sleep, and cannot establish causation. The honest summary: the evidence base for vitamin K2 and sleep is essentially empty right now.
How it works (mechanism)
Vitamin K2 (as MK-4 or MK-7) is best understood as a fat-soluble cofactor that activates vitamin K-dependent proteins through carboxylation. Its established roles are in:
- Calcium metabolism: Activating osteocalcin (bone) and Matrix Gla Protein (vascular), directing calcium away from soft tissues (Vermeer, 2012).
- Neurological support: Brain-expressed K-dependent proteins (Gas6, Protein S) influence myelination and apoptosis (Ferland, 2012).
The theoretical sleep connection, when it gets made, usually runs like this: calcium signalling plays a role in neurotransmitter release and circadian rhythm regulation; K2 influences calcium; therefore K2 might affect sleep. That chain has too many unvalidated links to be clinically meaningful. It is a hypothesis, not a mechanism proven in the context of sleep.
Some proponents also point to a possible interaction between K2 and vitamin D, noting that the two vitamins work together on calcium handling, and that vitamin D deficiency is associated with poorer sleep (Majid et al., 2018). But the "K2 and D together improve sleep" claim takes a real D-sleep association and adds an unproven K2 layer on top of it. That's a logical leap, not a finding.
Dose & timing if you try it
Because there is no sleep-specific evidence to guide dosing, any recommendation here has to be anchored in the general supplementation literature rather than sleep outcomes specifically.
- MK-7 form: 90–200 mcg/day is the range used in cardiovascular and bone-health trials (Knapen et al., 2015). MK-7 has a longer half-life (~72 hours) than MK-4, making once-daily dosing practical.
- MK-4 form: Higher doses (45 mg/day in three divided doses) have been used in Japanese bone-health research, but this is far above typical supplement levels and is not warranted without medical supervision.
- Timing: Take with the largest fat-containing meal of the day — K2 is fat-soluble and absorption improves significantly with dietary fat.
- No established sleep timing: Unlike melatonin, there is no circadian rationale for taking K2 at a specific time relative to bedtime.
If you decide to try K2 anyway — perhaps alongside vitamin D for general health — 90–180 mcg of MK-7 daily with dinner is a reasonable, well-tolerated starting point. Just don't expect your sleep tracker to confirm the decision.
Who should skip
- People on warfarin or other vitamin K antagonists: K2 directly interferes with anticoagulant therapy. Do not supplement without haematology or cardiology guidance.
- People taking other anticoagulants (e.g., rivaroxaban, apixaban): The interaction is less direct but worth flagging to your prescriber.
- Pregnant and breastfeeding individuals: K2 supplement safety in pregnancy has not been adequately studied; stick to dietary sources and consult your OB or midwife before supplementing.
- Those with fat-malabsorption conditions (e.g., Crohn's, cystic fibrosis, short bowel syndrome): absorption will be poor and underlying deficiency should be managed clinically.
- Anyone primarily motivated by sleep improvement: Given the absence of evidence, there are better-supported options (magnesium glycinate, melatonin at low doses, improved sleep hygiene) worth trying first.
Bottom line
Vitamin K2 is a legitimate and important nutrient for bone and vascular health, but calling it a sleep supplement would be a stretch the data cannot support. There are no human trials testing it for sleep quality. The theoretical mechanisms are plausible but unvalidated in this context. If you need a reason to take K2, look to bone density or cardiovascular risk conversations with your doctor — not your sleep diary.
If sleep quality is your primary goal, you'll get more mileage from interventions with actual evidence: consistent sleep-wake schedules, reduced evening light exposure, magnesium (particularly glycinate or threonate forms, which have shown modest sleep benefits in some trials), and — where appropriate — low-dose melatonin. Save the K2 conversation for your GP and a different health goal.
References
- Ferland, G. (2012). Vitamin K and the nervous system: an overview of its actions. Advances in Nutrition, 3(2), 204–212.
- Knapen, M. H. J., Drummen, N. E., Smit, E., Vermeer, C., & Theuwissen, E. (2015). Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporosis International, 24(9), 2499–2507.
- Majid, M. S., Ahmad, H. S., Bizhan, H., Hosein, H. Z. M., & Mohammad, A. (2018). The effect of vitamin D supplement on the score and quality of sleep in 20–50 year-old people with sleep disorders compared with control group. Nutritional Neuroscience, 21(7), 511–519.
- Vermeer, C. (2012). Vitamin K: the effect on health beyond coagulation — an overview. Food & Nutrition Research, 56, 5329.
Note: No high-quality clinical trials specifically examining vitamin K2 supplementation and sleep quality were identified in the literature. The references above support mechanistic or adjacent-health claims only.
```